Summary
Updated Aug 31, 2026
Nerissa Kreher is Director of Xeris Biopharma Holdings, Inc. (XERS). 2 SEC Form 4 filings on record going back to 2025, most recently on 2 July 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Nerissa Kreher has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Nerissa Kreher files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Beth Hecht - $1.04M of XERS open-market activity in the last 12 months
- Kevin McCulloch - $843K of XERS open-market activity in the last 12 months
- Steven Pieper - $426K of XERS open-market activity in the last 12 months
- Marla Persky - $211K of XERS open-market activity in the last 12 months
- John Patrick Shannon Jr. - $173K of XERS open-market activity in the last 12 months
- Dawn Halkuff - $122K of XERS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Nerissa Kreher?
Nerissa Kreher is a corporate insider, tracked as Director of Xeris Biopharma Holdings, Inc. (XERS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Nerissa Kreher submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Nerissa Kreher's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Nerissa Kreher and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
